Carmela Mannarelli
Azienda Ospedaliero-Universitaria Careggi(IT)University of Florence(IT)
Publications by Year
Research Areas
Myeloproliferative Neoplasms: Diagnosis and Treatment, Eosinophilic Disorders and Syndromes, Acute Myeloid Leukemia Research, Chronic Myeloid Leukemia Treatments, Kruppel-like factors research
Most-Cited Works
- → MIPSS70: Mutation-Enhanced International Prognostic Score System for Transplantation-Age Patients With Primary Myelofibrosis(2017)521 cited
- → Impact of calreticulin mutations on clinical and hematological phenotype and outcome in essential thrombocythemia(2013)406 cited
- → Clinical effect of driver mutations of JAK2, CALR, or MPL in primary myelofibrosis(2014)381 cited
- → Targeted deep sequencing in polycythemia vera and essential thrombocythemia(2016)298 cited
- → Presentation and outcome of patients with 2016 WHO diagnosis of prefibrotic and overt primary myelofibrosis(2017)175 cited
- → Genetic variation at MECOM, TERT, JAK2 and HBS1L-MYB predisposes to myeloproliferative neoplasms(2015)162 cited
- → Impact of mutational status on outcomes in myelofibrosis patients treated with ruxolitinib in the COMFORT-II study(2014)127 cited
- → Ropeginterferon alfa-2b versus phlebotomy in low-risk patients with polycythaemia vera (Low-PV study): a multicentre, randomised phase 2 trial(2021)126 cited
- → miRNA-mRNA integrative analysis in primary myelofibrosis CD34+ cells: role of miR-155/JARID2 axis in abnormal megakaryopoiesis(2014)123 cited
- → Driver mutations and prognosis in primary myelofibrosis: Mayo‐Careggi MPN alliance study of 1,095 patients(2017)117 cited